Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
828
-
Total 13F shares, excl. options
-
38,516,647
-
Shares change
-
-1,648,953
-
Total reported value, excl. options
-
$4,710,098,168
-
Value change
-
-$206,156,929
-
Put/Call ratio
-
388%
-
Number of buys
-
222
-
Number of sells
-
-392
-
Price
-
$122.29
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q3 2023
923 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q3 2023.
ISHARES TR - ISHARES BIOTECH (IBB) has 828 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38,516,647 shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (9,679,413 shares), MORGAN STANLEY (2,932,048 shares), GOLDMAN SACHS GROUP INC (2,421,484 shares), CITIGROUP INC (2,329,077 shares), JPMORGAN CHASE & CO (1,842,825 shares), UBS Group AG (1,420,583 shares), BNP PARIBAS ARBITRAGE, SNC (1,417,817 shares), Royal Bank of Canada (1,202,157 shares), COMMERCE BANK (723,513 shares), and WELLS FARGO & COMPANY/MN (673,326 shares).
This table shows the top 828 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.